Establishment of a novel hepatic steatosis cell model by Cas9/sgRNA-mediated DGK theta gene knockout

摘要

To investigate the role of diacylglycerol kinase theta (DGK theta) in lipid metabolism and insulin resistance, the present study generated an in vitro hepatic steatosis cell model by knockout of the DGK theta gene in liver cancer cell line HepG2 using CRISPR/Cas9 technology. The cell line was characterized by Oil Red O staining and shown to exhibit increased intracellular lipid accumulation, compared with that in wild-type liver cancer cell line HepG2. The gene expression levels of signaling proteins in pathways involved in lipid metabolism, insulin resistance and gluconeogenesis were also examined. The DGK theta-knockout HepG2 cells showed increased mRNA and protein expression levels of lipid synthesis-related genes, fatty acid synthase, peroxisome proliferator-activated receptor-gamma and sterol regulatory element-binding protein-1c, and decreased expression levels of the lipolysis-related gene, carnitine palmitoyltransferase1A. These changes may account for the increased intracellular lipid content of this cell line. The DGK theta-knockout HepG2 cells also exhibited an increased phosphorylation level of protein kinase C epsilon and decreased phosphorylation levels of insulin receptor substrate 1, mechanistic target of rapamycin and protein kinase B (also known as Akt). These changes have been reported to mediate insulin resistance. Taken together, an in vitro hepatic steatosis cell model was established in the present study, providing a valuable tool for understanding the pathogenesis of nonalcoholic fatty liver disease and associated insulin resistance, and for developing treatment strategies for this disease.